S&P 500 index data: S&P 500 Copyright ©
All data supplied by Morningstar Real-Time Data. U.S. intraday real-time exchange quotes are sourced from BATS when available. End-of-day quotes for Nasdaq, NYSE, and Amex securities will appear 15 minutes after close. Graph times are Eastern Standard. © Copyright Morningstar, Inc .
|Epizyme Announces Second Quarter 2014 Financial Results and Provides Corporate Update|
|Epizyme Presents Pre-Clinical Data and Early Clinical Observations from Ongoing Phase 1 Trial of EZH2 Inhibitor EPZ-6438 (E7438) at ASH Meeting on Lymphoma Biology|
|Epizyme, Inc. to Report Second Quarter Financial Results and Provide Corporate Update on August 13, 2014|
|Epizyme to Present at Upcoming Conferences in September|
|Epizyme Appoints Peter Ho, M.D., Ph.D., as Chief Development Officer and Michael Shih, J.D., as Vice President, Business Development|
|Epizyme, Inc. to Present at Upcoming Events in October|
|Epizyme Announces Clinical Data from Phase 1 Trial of EZH2 Inhibitor EPZ-6438 (E7438) to be Presented at EORTC-NCI-AACR Symposium|
|MYOS Corporation Announces Research Agreement With Human Metabolome Technologies America to Conduct Clinical Metabolomic Studies in Subjects Using Fortetropin(TM)|
|Epizyme Announces Resignation of President and Chief Financial Officer Jason Rhodes|
Click above to view more mutual fund data and stats for hmt - HMT Ltd.